Triamcinolone acetonide and Halobetasol propionate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triamcinolone acetonide (triamcinolone acetonide) and Halobetasol propionate (halobetasol propionate). Common drug interactions include seborrhoeic keratosis among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Triamcinolone acetonide and Halobetasol propionate. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Triamcinolone acetonide?

Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is often used in eczema. eHealthMe is studying from 19,594 Triamcinolone acetonide users. Check the latest studies of Triamcinolone acetonide.

What is Halobetasol propionate?

Halobetasol propionate has active ingredients of halobetasol propionate. eHealthMe is studying from 863 Halobetasol propionate users. Check the latest studies of Halobetasol propionate.

On Jul, 08, 2026

77 people who take Triamcinolone acetonide and Halobetasol propionate together, and have interactions are studied.

Triamcinolone acetonide and Halobetasol propionate drug interactions.

What are the common drug interactions of Triamcinolone Acetonide and Halobetasol Propionate, by gender? *:

female:

Seborrhoeic keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest)
Skin cancer
Skin hypertrophy (skin cells enlarges)
Sleep disorder
Sunburn
Abasia (inability to walk)
Alopecia (absence of hair from areas of the body)
Angiopathy (generic term for a disease of the blood vessels)
Cancer pain
Cardiac pacemaker replacement

male:

Drug ineffective
Eye pruritus (eye itching)
Injection site reaction
Abdominal discomfort
Abdominal pain
Application site eczema
Arthralgia (joint pain)
Conjunctivitis (pink eye)
Decreased appetite
Dry eye (lack of adequate tears)

What are the common drug interactions of Triamcinolone Acetonide and Halobetasol Propionate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Pruritus (severe itching of the skin)

10-19:

Decreased appetite
Dry eye (lack of adequate tears)

20-29:

Arthralgia (joint pain)

30-39:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)

40-49:

Rash pustular (redness with pustules)
Skin exfoliation (removal of the oldest dead skin cells)
Skin haemorrhage (bleeding into skin)
Skin plaque (red, scaly patches to appear on the skin)
Skin sensitisation (sensitive skin)
Dry skin
Eye discharge
Eye irritation
Eye pruritus (eye itching)
Injection site pain

50-59:

Back pain
Cancer pain
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

60+:

Gait disturbance
Disturbance in attention
Sinusitis (inflammation of sinus)
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Dyspnoea (difficult or laboured respiration)
Feeling cold
Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)
Impetigo (contagious skin infection)
Influenza like illness

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 28 people, 36.36%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 28 people, 36.36%
Pain: 8 people, 10.39%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 7.79%
Immunodeficiency Common Variable: 6 people, 7.79%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 7.79%
Neuropathy Peripheral (surface nerve damage): 4 people, 5.19%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone acetonide and Halobetasol propionate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously